Abstract:Transforming growth factor beta (TGF beta) is a secreted growth and differentiation factor that influences vital cellular processes like proliferation, adhesion, motility, and apoptosis. Regulation of the TGF beta signaling pathway is of key importance to maintain tissue homeostasis. Perturbation of this signaling pathway has been implicated in a plethora of diseases, including cancer. The effect of TGF beta is dependent on cellular context, and TGF beta can perform both anti- and pro-oncogenic roles. TGF beta acts by binding to specific cell surface TGF beta type I and type II transmembrane receptors that are endowed with serine/threonine kinase activity. Upon ligand-induced receptor phosphorylation, SMAD proteins and other intracellular effectors become activated and mediate biological responses. The levels, localization, and function of TGF beta signaling mediators, regulators, and effectors are highly dynamic and regulated by a myriad of post-translational modifications. One such crucial modification is ubiquitination. The ubiquitin modification is also a mechanism by which crosstalk with other signaling pathways is achieved. Crucial effector components of the ubiquitination cascade include the very diverse family of E3 ubiquitin ligases. This review summarizes the diverse roles of E3 ligases that act on TGF beta receptor and intracellular signaling components. E3 ligases regulate TGF beta signaling both positively and negatively by regulating degradation of receptors and various signaling intermediates. We also highlight the function of E3 ligases in connection with TGF beta's dual role during tumorigenesis. We conclude with a perspective on the emerging possibility of defining E3 ligases as drug targets and how they may be used to selectively target TGF beta-induced pro-oncogenic responses.

Key Role for Ubiquitin Protein Modification in TGFβ Signal Transduction

E3 Ubiquitin Ligases: Key Regulators of TGFβ Signaling in Cancer Progression

E3 Ubiquitin Ligases: Key Regulators of TGF Signaling in Cancer Progression

The Regulation of TGF-β/SMAD Signaling by Protein Deubiquitination

Regulation of the TGF-β Pathway by Deubiquitinases in Cancer.

Reversible Ubiquitination Regulates the Smad/TGF-β Signalling Pathway

Regulation of TGF-beta signalling by protein phosphatases.

To Ub or not to Ub: a regulatory question in TGF-β signaling.

Post-translational regulation of TGF-β receptor and Smad signaling.

To Ub or not to Ub: a regulatory question in TGF- signaling

Post‐translational Regulation of TGF‐β Receptor and Smad Signaling

Regulation of TGF-β Superfamily Signaling by SMAD Mono-Ubiquitination

Posttranslational Regulation of Smads

TGF-β signaling pathway mediated by deubiquitinating enzymes

The Deubiquitinating Enzyme UCH37 Interacts with Smads and Regulates TGF-β Signalling

Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-β signaling

Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling.

Negative Regulation of TGF-β Receptor/smad Signal Transduction

The Post-translational Modifications of Smurf2 in TGF-beta Signaling

The Role of E3 Ubiquitin Ligase Smurfs in Bmp and Tgf-Bata Signaling in Bone Cells

Roles of Ubiquitination in the Crosstalk Between Tumors and the Tumor Microenvironment (Review)